The Technology: The Anatomy of a Spinal Cord and Nerve Root Stimulator: The Lead and the Power Source
|
|
- Paulina George
- 5 years ago
- Views:
Transcription
1 Blackwell Publishing IncMalden, USAPMEPain Medicine American Academy of Pain Medicine20067S1S27S34 Original ArticleThe TechnologyBradley PAIN MEDICINE Volume 7 Number S The Technology: The Anatomy of a Spinal Cord and Nerve Root Stimulator: The Lead and the Power Source Kerry Bradley, MS Advanced Bionics Corporation, A Boston Scientific Company, Valencia, California, USA ABSTRACT ABSTRACT Introduction S Spinal cord stimulation (SCS) has been used for over 30 years to treat a variety of pain conditions. Success rates in SCS have improved due to more judicious patient selection, standardization of techniques, understanding of technical and clinical goals, and, quite importantly, advances in the stimulation technology. This article discusses characteristics of the stimulating leads and the power source and how they contribute to optimizing SCS therapy. Key Words. Spinal Cord Stimulation; Lead; Electrode; Rechargeable pinal cord stimulation (SCS) has been used for over 30 years to treat a variety of pain conditions. The most successful results have been in the treatment of neuropathic pain, often with a vascular component [1]. In SCS, an array of stimulating metal contacts is placed in the dorsal epidural space. These contacts, connected to a pulse generator, are then programmed in contact combinations of anodes and cathodes, with the intent of generating an electric field, which stimulates the axons of dorsal root (DR) and dorsal column (DC) fibers in the spinal column. Stimulation of these fibers results in inhibition of activity in the lateral spinothalamic tract (a known pain pathway), as well as increased activity in descending antinociceptive pathways [2]. Clinically, SCS creates an epiphenomenon called paresthesia, which has been described by patients as a tingling sensation in their skin. In the application of SCS, a crucial technical result that is correlated to a successful clinical outcome is the overlap of the painful areas with paresthesia [3]. In order to optimize this result, the SCS system, like any neurostimulation system, must provide adequate neural selectivity; that is, maximal control over stimulation of the targeted nerves while avoiding stimulation of undesired neurons. Technology has accelerated in Reprint requests to: Kerry Bradley, MS, Rye Canyon Loop, Valencia, CA 91355, USA. Tel: ; Fax: ; kerrybradley@earthlink.net. the last decade to continually improve this capability. This article will discuss two categories of technology that enable the improvement in stimulation selectivity, the lead and the power source. Stimulation Selectivity In common electrical stimulation applications, such as cardiac pacing and defibrillation, there are usually no more than 1 2 stimulating contacts near the tissue to be stimulated, e.g., a bipolar pair of contacts placed in the right ventricular apex for bradycardia pacing. Also, the physiologic result of the stimulation is usually binary. For example, in a cardiac pacer, enough charge needs to be delivered to the endocardial stimulation site to trigger a heart contraction, and no more [4]. In neurostimulation applications, however, the nerves surrounding the contacts often have multiple functions (e.g., sensory, motor, autonomic), complex geometries (e.g., DRs, DCs), and differing thresholds [5]. The intent of neurostimulation is to activate only those nerves that create the therapeutic benefit. This benefit is proportional to the number of targeted nerves stimulated and inversely related to the number of undesired nerves stimulated. Thus, in neurostimulation, recruitment is a graded function and should be confined to the targeted nerves. In sum, neurostimulation differs greatly from other electrical stimulation in that it requires a high degree of stimulation selectivity. This requirement is the main driving force behind the technological devel- American Academy of Pain Medicine /06/$15.00/S27 S27 S34
2 S28 Bradley opments in lead and stimulator power source design. The Lead Two types of lead are presently in use for SCS: percutaneous and paddle. The main differences between the two types have been described in the literature [6 8]. Briefly, percutaneous leads are catheter-like, being cylindrical and flexible, and these mechanical features allow them to be introduced into the spinal column via a spinal needle (Touhy, Husted, or the like). The contacts on the leads are cylindrical, most commonly 3 mm in length, and made of platinum iridium alloys. The lead itself consists of an isodiametric polyurethane body containing wires that connect the intraspinal contacts to a proximal connector, for connection to the stimulator electronics [6]. Paddle leads, in contrast, differ in that their distal ends are relatively flat and wide, with round or rectangular plate contacts placed on one side of the flat portion, and are constructed of a flexible silicone. Given their shape, most paddle leads must be placed via surgical procedure, such as laminotomy or laminectomy [8]. The proximal portion of the paddle is typically similar to the percutaneous leads, terminating in one or two long isodiametric bodies that provide connection to the stimulating electronics. From a stimulation selectivity standpoint, the key differences between lead types can be broken down into several categories: number of contacts, intercontact center-to-center spacing, contact length, contact width, contact shape, intraspinal lead shape, and for paddle designs with multiple columns, the relative orientation of the contacts among columns [9,10]. The specifics of these features will be described for both percutaneous and paddle-type leads. Percutaneous Leads All modern percutaneous leads have multiple contacts, ranging from 4 to 8 (see Figure 1). Percutaneous leads with multiple contacts have been shown to provide statistically improved long-term outcomes [3], primarily due to their ability to Figure 1 Percutaneous leads of 4 mm and 9 mm centerto-center spacing, respectively. Figure 2 Effects of center-to-center spacing on stimulation field. Widely spaced contacts on left have greater rostrocaudal and lateral stimulation field, where narrowly spaced contacts on right have more confined stimulation field, laterally and rostrocaudally [15] (reprinted with permission of the authors). allow for postoperative reprogramming to capture stimulation targets following micro- or macromigration. For leads placed at or near the physiological midline, mathematical modeling has shown that the center-to-center spacing between active contacts is a key factor in determining the fiber types to be stimulated. Lead models where the anode(s) and cathode were separated by a centerto-center spacing of 4 mm have been shown to be mathematically optimal for preferentially stimulating DC fibers over DR fibers [11,12]. Clinically, leads that use center-to-center anode cathode separations of <10 mm have been shown to be superior at capturing challenging pain targets, such as covering the low back with paresthesia [13,14]. The value of narrow center-to-center spacing is that it confines the stimulation field along the axis of the lead, as well as increases the peak of the stimulation field beneath the cathode (see
3 The Technology Figure 2). Typically, the DC fibers are the primary targets in SCS, as the DC contains fibers of passage from all cutaneous regions caudal to the stimulating contacts, so stimulating DC fibers means maximizing the stimulation paresthesia coverage at any segmental level. Also, the DC contains predominantly touch and vibration sensory fibers, which are least likely to generate functional deficits (motor or autonomic side effects) when stimulated maximally. In contrast, primary activation of DR fibers would generate paresthesia in only a few dermatomes at the segmental location of the stimulating contacts [16,17]. While this may be a specific stimulation goal for a given patient, i.e., where the SCS device functions as a dorsal root stimulator, in general, broad regions of paresthesia should be more likely to maintain paresthesia pain overlap if the pain happens to migrate to different body locations, as in complex regional pain syndrome [2]. Additionally, DRs carry a wide range of sensory fibers (pain as well as touch and vibration) and make more direct synaptic reflex links with the musculoskeletal system. Maximal stimulation of DR fibers may then result in pain as well as motor deficits. Thus, it may be clinically advantageous to use leads with narrow center-tocenter spacing as this should result in more selective activation of DC fibers. The cost of using narrow combinations is an increase in stimulation energy [11], but such selectivity may mean the difference between a successful and failed technical result [14]. Another key aspect of narrow intercontact spacing is the increased targeting resolution enabled by multiple contacts in a confined region. In keeping with the goal of stimulation selectivity, a prominent factor in the success of an SCS implant is the placement of the stimulating contact(s) as close as possible to the desired neural targets to optimize paresthesia pain overlap [18]. This is due to the nature of electric fields: the activation field strength rapidly falls off (inverse cube root) with distance from the contact to the nerve [19], so placement of the contact will determine which nerves are stimulated first. If first-stimulated nerves are not the targeted ones, an increase in stimulation energy (amplitude or pulse width) is necessary to reach the neural targets. This can mean sensations in undesired locations and, possibly, motor activation prior to target capture [17]. Indeed, this is the reason why significant physician effort is expended during intraoperative placement of the lead [20]. Having a large number of contacts within a confined space increases the likelihood of S29 having a stimulating contact close to the neural target. Additionally, slight migration of the lead may result in a shift of the activating field and loss of the desired paresthesia. If a large number of narrowly spaced contacts are employed on a lead, slight migrations may be accounted for by reprogramming [3]. Paddle Leads Modern paddle leads also have multiple contacts, ranging from 2 to 16, arranged in single or multiple columns (see Figure 3). Paddle leads have been shown to have superior technical results when compared with percutaneous leads [21]. The primary reason for the improved stimulation appears to be mechanical. The flat, relatively rigid shape of the paddle lead tends to compress the pliable dorsal dural sac. This reduces the distance between the contact and the DCs, and thus increasing the likelihood of primary DC fiber activation [22]. Nonetheless, percutaneous leads can still achieve technical results similar to paddles. In a prospective, randomized comparison, paddle leads provided statistically superior paresthesia pain overlap when programmed with simple bipolar combinations. However, when the contact combinations were exhaustively tested and the optimal contact combination was programmed both for percutaneous lead and for the paddle, the statistical difference disappeared [21]. This result indicates that stimulation selectivity is a result of several factors: number of contacts, contact and lead geometry, and electric field shaping via the anode cathode combination [23]. Additionally, in comparisons of percutaneous and paddle leads, the radial nature of the percutaneous contact allows current flow in a radial direction. This has been shown to increase the likelihood of dorsal current flow that can result in uncomfortable axial sensations via stimulation of sensory fibers in the ligamentum flavum at therapeutic current levels. On paddle leads with ventrally directed contacts, this result was not observed [22]. Although the nature of percutaneous lead implant makes it difficult to control the dorsoventral position of the contacts, mathematical modeling has shown that percutaneous contacts, when placed directly on the dura mater, achieve near unidirectional current flow toward the spinal cord, similar to that of paddle leads (see Figure 4) [23]. Indeed, those same models have shown that placement of a single percutaneous lead on midline can achieve slightly superior DC
4 S30 Figure 3 Typical two-column paddle leads. penetration when compared with paddles with wide (4 mm) contacts [23]. The relative orientation of contacts on paddle leads with multiple columns of contacts is also of importance. Mathematical models suggest that superior DC penetration is achieved when the active contacts are arranged on the lead in perfect parallel, that is, with contacts aligned rather than staggered [10]. When contacts are staggered, the cathodic fields do not optimally superimpose and, if two columns of narrow bipoles or guarded cathodes are programmed, greater anode-cathode cancellation can occur. Novel paddle designs that seek to maximize DC penetration have been developed and clinically evaluated. The most notable of these was the transverse tripole design [24]. Inspired by results from mathematical modeling, which revealed that DR fibers would be typically activated prior to DC fibers in nominal SCS, the transverse tripole lead sought to reverse this recruitment order by judicious contact placement on the paddle. The transverse tripole consisted of two long lateral contacts to the left and right sides of the approximately 10- Bradley mm-wide paddle, with two smaller contacts placed longitudinally in the center of the paddle, between the anodes. The intent of this design was to program the lateral contacts as anodes proximal to the DR fibers. The anodic field would then hyperpolarize the roots and allow for the center contacts, programmed as cathodes, to achieve selective activation of the DC fibers and deeper penetration into the DCs. Clinically, the system was evaluated in a multicenter study, which showed that very selective paresthesia could be generated in many dermatomes caudal to the segmental level of the paddle [25]. The cost of such selectivity, again, was increased stimulation energy [26]. Single Versus Dual Leads In the first two decades of SCS, a single lead was placed as close to physiological midline as possible in each patient. This was due primarily to limitations in technology, as only a single lead with a few contacts could be driven by early stimulators [27]. In recent years, with the advent of stimulators which can deliver stimulation to two leads, there has been a trend toward the implant and use of dual, parallel leads over a specific spinal segment. There have been several reasons for doing so: 1) placement of two leads, one to each side of the physiological midline, can provide greater control over the laterality of the paresthesia pattern for patients with bilateral pain, a common condition [7]; 2) it is known that percutaneous leads tend to migrate slightly in the acute phase of implant and having two leads, with a larger number of contacts at the targeted spinal segment, allows for maximum programming flexibility in order to recapture the neural target [28]; and 3) mathematical modeling has shown that, for certain anatomic and geometric conditions, two leads straddling the physiological midline can create stimulation fields that superimpose and achieve good penetration in the DCs [10]. All of these reasons have certain A B Figure 4 Effects of dorsoventral position of percutaneous lead in epidural space. (A) Intimate dural contact yields minimal dorsal current flow. (B) If contact is located more dorsally in epidural space, current flow becomes more radial and may activate neurons in posterior regions [23] (reprinted with permission of the authors).
5 The Technology merit. Nonetheless, the placement of a single lead on or very near the physiological midline has been shown clinically and in mathematical modeling to be the optimal stimulation construct, as it achieved the best DC activation at the lowest stimulation energy [10,21]. The choice of number of leads and their placement in the spinal cord depend upon the physician s technique and his/her goals for each patient, as well as the patient s pain pattern. The Power Source As multiple stimulating contacts on narrowly spaced leads have been shown to improve clinical outcomes, and narrowly spaced contact combinations require higher stimulation energies, it becomes apparent that significant stimulation power will be required to drive such systems. Additionally, the growing use of dual-lead implants also requires an increase in stimulation energy. These new technologies and techniques entail special requirements for the stimulation power source, both from a battery standpoint and from the method for generating the stimulating field, i.e., the manner of delivering the stimulation pulse. Neurostimulators presently are powered using one of three different power sources: radiofrequency coupling (RF), primary cell, and rechargeable cell. RF stimulators were historically the first to be used for SCS, in the 1970s and 1980s. The first primary cell devices, employing lithiumthionyl-chloride batteries derived from pacemaker technology, appeared in 1980 [27]. These two choices were the only ones available for approximately two decades, and the clinical tradeoffs between them were relatively clear: primary cell implantable pulse generators (IPG) are more convenient for the patient, as the entire system is fully implantable and could be used during most activities of daily living. Primary cell IPGs, however, have limited life (average of 4 years, although sometimes less than 1 year), and are relatively large compared with similar bradycardia pacemaker devices [29]. The limited battery life also implies that the stimulation power may be compromised [1]. In contrast, RF units do not suffer from stimulation power constraints, as their power source is external, and has no specified end of life. RF units can drive multiple stimulation channels, up to 16 contacts, and be programmed with relatively high stimulation amplitudes, pulse width, and rate values [30]. However, RF units are very inconvenient for patients, as they require an S31 antenna to be worn over the implant during use of the device. This means that patients cannot sleep, shower, or swim with the equipment and, if the patient has sensitive skin, the taping of the antenna might result in chronic irritation [6]. In the last two decades, a revolution in portable consumer electronics took place, largely enabled by the development and use of lithium-ion batteries. Li-ion technology has many features, such as high energy density in a small size, memory-less charge retention behavior, and safer design [31], which make it possible to build a rechargeable implantable-grade medical device. In 2004, the first rechargeable cell SCS IPG became commercially available, which eliminated many of the tradeoffs between primary cell IPGs and RF devices. With the introduction of Li-ion rechargeable batteries in fully implantable neurostimulators, the stimulation power available in an IPG is no longer limited by concerns about short device life. Presently available rechargeable IPGs have lifetimes up to 9 years, and device size is now generally correlated to recharge interval rather than time-to-replacement. Recharge interval is dependent upon several parameters: stimulation energy, depth of discharge, useable battery capacity, state of battery degradation, depth of discharge, etc. In the simplest sense, the more stimulation energy a patient uses (e.g., high-amplitude settings and/or round-the-clock SCS usage), the more frequently a patient will recharge. Similarly, a larger battery capacity will extend the time between recharges, but will also require more time spent recharging by the patient to fill a depleted battery. Additionally, battery degradation over time and the depth of battery discharge must be understood. Li-ion cells have a fixed number of charge discharge cycles and the battery degrades slightly with each cycle. Over time, as the battery is cycled, the battery holds less charge. Also, in certain Li-ion technologies, if the battery is allowed to reach full discharge, chemical changes to the battery can take place that further degrade the battery s capacity. From the patient s point of view, device implant depth and the interface with the IPGs recharging equipment can be important [32]. In general, rechargeable neurostimulators require new awareness and responsibilities, but have also enabled the implementation of newer stimulation technologies [33]. One new feature made possible by rechargeable cell IPGs is the use of a current-controlled stimulation architecture. When controlling the stimu-
6 S32 lating current, there are several methods. The standard current-controlled system uses a single source for all contacts. In contact combinations where there is a single anode and cathode, the current to each contact is precisely controlled. However, if there is more than one anode or cathode in the contact combination, the current at each contact is no longer controlled; the impedance of each contact will determine where the current flows [34]. This impedance can change over time, as well as change differentially among the contacts [35]. This can affect the stimulation outcome, as a large impedance on a few contacts may so restrict the flow of current that the stimulation field is drastically altered, to the detriment of the therapy [36]. This challenge can be overcome in current-controlled systems that dedicate a current-source to each contact, such as that found in multiple independent constant-current (MICC) stimulation architecture. In such systems, the current at each contact is controlled, allowing for shaping of the stimulation field with minimum impedance sensitivity to directing current flow and designed to provide improved neural selectivity. To better understand the theoretical reasons for using MICC stimulation, a simple cascade of relationships between the nerve and the contact is instructive (see Figure 5). Since the nerve is stimulated when the transmembrane potential is driven to threshold [37], then controlling the A nerve fires when the transmembrane potential is driven to threshold The transmembrane potential is driven by the spatial gradient of the Electric Field at the nerve The Electric Field is proportional to the current density at the nerve Cathode Anode + Bradley transmembrane potential of the targeted nerves is a key factor to success. When stimulating extracellularly, the transmembrane potential is driven by the second spatial derivative of the electric field along the nerve [38]. This electric field is directly proportional to the current density, which in turn is determined by the current that flows along the nerve [39]. Thus, direct control of the current along the nerve is key to controlling the stimulation of the nerve [40]. If a MICC system is used, then the current flowing at the targeted nerve, often a few millimeters from the stimulating contacts, should be precisely controlled when using many contacts and should achieve the desired neural selectivity. Also, with rechargeable-cell systems, the capability of much larger stimulation pulse parameter outputs are possible, such as rate and pulse width. Studies have suggested that very high rates of stimulation in SCS may be useful for recapture of relief in the presence of breakthrough pain [30]. Additionally, relatively long pulse width values can be programmed, and these may result in more recruitment of smaller DC fibers [41], and thus achieve wider regions of paresthesia coverage. Conclusion Advances in lead technology, such as the increase in the number of contacts, with a concomitant decrease in the distance between them, have + Depolarized + Hyperpolarized + All geometry being equal, the current density is a direct function of the CURRENT at the nerve Therefore, CURRENT at the nerve is a key determinant of neurostimulation Figure 5 Cascade of relationships between nerve stimulation and electric field generation.
7 The Technology enabled better dorsal DC selectivity. Also, dual percutaneous leads of multiple contacts and paddle leads with multiple columns of contacts are now commonly used to create complex stimulation fields to achieve better neural targeting. With these newer lead technologies and techniques, the power source for neurostimulators has also advanced to use rechargeable lithium-ion cells. Use of rechargeable technology not only results in extended stimulator lifetime, but also enables higher stimulation power, such that current-controlled stimulation can be employed to control stimulation fields and further improve neural selectivity. Editors Note: At the time of this publication, there is a lack of prospective controlled clinical trials demonstrating improved efficacy or clinical outcomes of one manufacturer system (lead or generator design) over another. References 1 Barolat G. Spinal cord stimulation for persistent pain management. In: Gildenberg PL, Tasker RR, Franklin PO, eds. Textbook of Stereotactic and Functional Neurosurgery. New York: McGraw- Hill; 1998: Linderoth B, Foreman RD. Physiology of spinal cord stimulation: Review and update. Neuromodulation 1999;2: North RB, Ewend MG, Lawton MT, Piantadosi S. Spinal cord stimulation for chronic, intractable pain: Superiority of multi-channel devices. Pain 1991;44: Hayes DL, Furman S. Cardiac pacing: How it started, where we are, where we are going. PACE 2004;27(5): Barolat G. Epidural spinal cord stimulation: Anatomical and electrical properties of the intraspinal structures relevant to spinal cord stimulation and clinical correlations. Neuromodulation 1998;1(2): Barolat G, North RB. Spinal cord stimulation equipment and implantation techniques. In: Burchiel K, ed. Surgical Management of Pain. New York: Thieme Medical Publishers, Inc.; 2002: Oakley JC. Spinal cord stimulation: Patient selection, technique, and outcomes. Neurosurg Clin N Am 2003;14: Barolat G. Experience with 509 plate electrodes implanted epidurally from C1 to L1. Stereotact Funct Neurosurg 1993;61: Holsheimer J, Struijk JJ, Tas NR. Effects of electrode geometry and combination on nerve fibre selectivity in spinal cord stimulation. Med Biol Eng Comput 1995;33: S33 10 Holsheimer J, Wesselink WA. Effect of anode cathode configuration on paresthesia coverage in spinal cord stimulation. Neurosurgery 1997;41: Holsheimer J, Wesselink WA. Optimum electrode geometry for spinal cord stimulation: The narrow bipole and tripole. Med Biol Eng Comput 1997;35: Manola L, Holsheimer J, Veltink PH. Technical performance of percutaneous leads for spinal cord stimulation: A modeling study. Neuromodulation 2005;8(2): Law JD. Spinal stimulation: Statistical superiority of monophasic stimulation of narrowly separated, longitudinal bipoles having rostral cathodes. Appl Neurophysiol 1983;46: Law JD. Targeting a spinal stimulator to treat the failed back surgery syndrome. Appl Neurophysiol 1987;50: Alo KM, Holsheimer J. New trends in neuromodulation for the management of neuropathic pain. Neurosurgery 2002;50(4): Dimitrijevic MR, Faganel J, Sharkey PC, Sherwood AM. Study of sensation and muscle twitch responses to spinal cord stimulation. Int Rehabil Med 1980;2: Hunter JP, Ashby P. Segmental effects of epidural spinal cord stimulation in humans. J Physiol 1994;474(3): Oakley JC, Prager JP. Spinal cord stimulation mechanisms of action. Spine 2002;27(22): Struijk JJ, Holsheimer J, van Veen BK, Boom HBK. Epidural spinal cord stimulation: Calculation of field potentials with special reference to dorsal column nerve fibers. IEEE Trans Biomed Eng 1991;38(1): Lazorthes Y, Verdie J-C. Technical evolution and long-term results of chronic spinal cord stimulation. In: Lazorthes Y, Upton ARM, eds. Neurostimulation: An Overview. Mt Kisco, New York: Futura Publishing Co., Inc.; 1985: North RB, Kidd DH, Olin JC, Sieracki JM. Spinal cord stimulation electrode design: Prospective, randomized controlled trial comparing percutaneous and laminectomy electrodes Part I. Technical outcomes. Neurosurgery 2002;51: North RB, Lanning A, Hessels R, Cutchis PN. Spinal cord stimulation with percutaneous and plate electrodes: Side effects and quantitative comparisons. Neurosurg Focus 1990;2: Manola L, Holsheimer J. Technical performance of percutaneous and laminectomy leads analyzed by modeling. Neuromodulation 2004;7(4): Holsheimer J. Effectiveness of spinal cord stimulation in the management of chronic pain: Analysis of technical drawbacks and solutions. Neurosurgery 1997;40(5): Oakley JC, et al. Transverse tripolar spinal cord stimulation: Results of an international multicenter study. Neuromodulation 2006 (in press).
8 S34 26 Struijk JJ, Holsheimer J, Spinc le GHJ, Gielen FLH, Hoekema R. Theoretical performance and clinical evaluation of transverse tripolar spinal cord stimulation. IEEE Trans Biomed Eng 1998;6(3): Lazorthes Y, Morucci J-P, Clemente G. Biotechnological basis of neurostimulation. In: Lazorthes Y, Upton ARM, eds. Neurostimulation: An Overview. Mt Kisco, New York: Futura Publishing Co., Inc.; 1985: Barolat G. Reply to a letter to the editor. (2001;4:35 6). Neuromodulation 2001;4(2): Kumar K, Malik S, Demeria D. Treatment of chronic pain with spinal cord stimulation versus alternative therapies: Cost-effectiveness analysis. Neurosurgery 2002;51: Bennett DS, Alo KM, Oakley J, Feler CA. Spinal cord stimulation for complex regional pain syndrome I [RSD]: A retrospective multicenter experience from 1995 to 1999 of 101 patients. Neuromodulation 1999;2(3): Linden D. Handbook of Batteries, 2nd edition. New York: McGraw-Hill; Bedder M. Overview of rechargeable SCS systems. Presented at the Ninth Meeting of the North American Neuromodulation Society, November 10 12, 2005, Washington, DC. 33 Anonymous. Advanced Bionics Physician Implant Manual Precision TM Implantable Pulse Generator Model SC1110. Valencia, CA: Advanced Bionics Corporation; Oakley JC, Krames E, Weiner R, Grandhe V, Moffitt M, Bradley K. Bilateral current fractionalization in spinal cord stimulation. Abstracts of the Bradley Ninth Meeting of the North American Neuromodulation Society, November 10 12, 2005, Washington, DC. 35 Oakley J, Prager J, Krames E, Weiner R, Stamatos J, Bradley K. Variability of contact impedance over time in spinal cord stimulation. Abstracts of the American Society of Stereotactic and Functional Neurosurgery Biennial Meeting, Neuromodulation: Defining the Future. October 1 3, Cleveland, OH. 36 Yearwood TL. Using current fractionalization to overcome SCS contact impedance variability and nonuniformity in failed back surgery syndrome: A case study. Abstracts of the Ninth Meeting of the North American Neuromodulation Society, November 10 12, 2005, Washington, DC. 37 Yeomans JS. Principles of Brain Stimulation, 1st edition. New York: Oxford University Press; Rattay F. Analysis of models for extracellular fiber stimulation. IEEE Trans Biomed Eng 1989;36(7): Plonsey R, Barr R. Bioelectricity: A Quantitative Approach, 2nd edition. New York: Kluwer Academic/Plenum Publishers; Mortimer JT. Motor prostheses. In: Brooks VB, ed. Handbook of Physiology, Section I: The Nervous System, Vol. II, Motor Control, Part I. Bethesda, MD: American Physiological Society; 1981: Meyerson B. Commentary on: Holsheimer J. Effectiveness of spinal cord stimulation in the management of chronic pain: Analysis of technical drawbacks and solutions. Neurosurgery 1997;40(5):990 9.
Precision TM. Plus. Rechargeable Spinal Cord Stimulation System
Precision TM Plus Rechargeable Spinal Cord Stimulation System Precisely Target Pain with the Precision Plus SCS System SmoothWave Technology The Power of Multiple Independent Current Control Only the Precision
More informationSpinal cord stimulation (SCS) is a reversible augmentative
CLINICAL STUDIES SPINAL CORD STIMULATION ELECTRODE DESIGN: PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL COMPARING PERCUTANEOUS AND LAMINECTOMY ELECTRODES PART I: TECHNICAL OUTCOMES Richard B. North, M.D.
More informationSPINAL cord stimulation (SCS) is the most common
Computational Analysis of Kilohertz Frequency Spinal Cord Stimulation for Chronic Pain Management Scott F. Lempka, Ph.D., Cameron C. McIntyre, Ph.D., Kevin L. Kilgore, Ph.D., Andre G. Machado, M.D., Ph.D.
More informationAuthor Information. Presenting Symptom: Burning in right foot> Chronic low back pain
Author Information Full Names: Erica Patel, MD Kiran V. Patel, MD Presenting Symptom: Burning in right foot> Chronic low back pain Case Specific Diagnosis: Chronic low back pain and radicular pain Learning
More informationQuantitative Electrophysiology
ECE 795: Quantitative Electrophysiology Notes for Lecture #10 Wednesday, November 22, 2006 14. FUNDAMENTALS OF FUNCTIONAL ELECTRICAL STIMULATION (FES) We will look at: Design issues for FES Subthreshold
More informationInnovations In Neuromodulation. Maged Guirguis, MD Director Of Research Pain Management
Innovations In Neuromodulation Maged Guirguis, MD Director Of Research Pain Management 1 2 Pain Pathway 3 Gate Theory In the dorsal horn (where pain signals relay), there is a gate that opens and closes
More informationReview Article Spinal Cord Stimulation: The Clinical Application of New Technology
Anesthesiology Research and Practice Volume 2012, Article ID 375691, 5 pages doi:10.1155/2012/375691 Review Article Spinal Cord Stimulation: The Clinical Application of New Technology Dominic Hegarty 1,
More informationIllumina 3D Portfolio
illumina 3D Portfolio Only the Illumina 3D Portfolio can customize therapy by delivering multiple waveforms to a precise neural target. Illumina 3D Portfolio Right Target. Right Waveform. Customized Therapy.
More information2016 HF10 THERAPY REIMBURSEMENT REFERENCE GUIDE
206 HF0 THERAPY REIMBURSEMENT REFERENCE GUIDE HF0 therapy, delivered by the Nevro Senza System, is a new high-frequency spinal cord stimulation technology designed to aid in the management of chronic intractable
More informationEffects of Movement and Postural Positions in Spinal Cord Stimulation in the New Rechargeable Systems
Pain Physician 2014; 17:345-352 ISSN 1533-3159 Prospective Study Effects of Movement and Postural Positions in Spinal Cord Stimulation in the New Rechargeable Systems David Abejon, MD, PhD 1,2, Pablo Rueda,
More informationNovel Minimally Invasive Wireless Nanotechnology Neuromodulation System in the Management of Chronic Pain Syndromes
Novel Minimally Invasive Wireless Nanotechnology Neuromodulation System in the Management of Chronic Pain Syndromes Laura Tyler Perryman* Stimwave Technologies, Inc. 1310 Park Central Blvd South, Pompano
More informationParesthesia-Independence: An Assessment of Technical Factors Related to 10 khz Paresthesia-Free Spinal Cord Stimulation
Pain Physician 2017; 20:331-341 ISSN 1533-3159 Prospective Evaluation Paresthesia-Independence: An Assessment of Technical Factors Related to 10 khz Paresthesia-Free Spinal Cord Stimulation Giuliano De
More informationNeurostimulation Systems
Neurostimulation Systems Expanding the Array of Pain Control Solutions PROVEN EFFECTIVE FOR SIMPLE PAIN ITREL 3 SYSTEM For simple neuropathic pain Totally implantable for enhanced quality of life Easy
More informationStimulation Ranges, Usage Ranges, and. Paresthesia Mapping During Occipital Nerve Stimulation. Introduction ORIGINAL ARTICLE ABSTRACT
NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE Volume 11 Number 1 2008 http://www.blackwell-synergy.com/loi/ner ORIGINAL ARTICLE Stimulation Ranges, Usage Ranges, and Blackwell Publishing Inc Paresthesia
More informationNevro Reimbursement Support
HF10 therapy, delivered by the Nevro Senza System, is the high-frequency spinal cord stimulation technology operated at 10,000 Hz designed to aid in the management of chronic intractable pain of the trunk
More informationAid to Programming: Algorithm and Check List for Electrode Configurations. Patient name: Medical Record No.
1 Aid to Programming: Algorithm and Check List for Electrode Configurations Patient name: Medical Record No. Date of Birth: Month Day Year Diagnosis: DBS target: DBS side: The designations for the contacts
More informationSee Policy CPT/HCPCS CODE section below for any prior authorization requirements
Effective Date: 1/1/2019 Section: SUR Policy No: 395 1/1/19 Medical Policy Committee Approved Date: 8/17; 2/18; 12/18 Medical Officer Date APPLIES TO: Medicare Only See Policy CPT/HCPCS CODE section below
More information2 016 HF10 THERAPY HOSPITAL OUTPATIENT DEPARTMENT AND AMBULATORY SURGERY CENTER REIMBURSEMENT REFERENCE GUIDE
HF10 therapy, delivered by the Nevro Senza System, is a new high-frequency spinal cord stimulation technology designed to aid in the management of chronic intractable pain of the trunk/limbs, including
More informationDELSYS. Purpose. Hardware Concepts. Software Concepts. Technical Note 101: EMG Sensor Placement
Technical Note 101: EMG Sensor Placement Purpose This technical note addresses proper placement technique for Delsys Surface EMG Sensors. The technique is demonstrated through an experiment in which EMG
More informationForward Looking Statements and Further Information
JANUARY 2015 [ 1 ] Forward Looking Statements and Further Information SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements. All statements other than
More informationPacing Lead Implant Testing. Document Identifier
Pacing Lead Implant Testing 1 Objectives Upon completion of this presentation, the participant should be able to: Name the two primary surgical options for implanting pacing leads Describe three significant
More informationHighmark Medical Policy Bulletin
Highmark Medical Policy Bulletin Section: Miscellaneous Number: Z 7 Topic: Electrical Nerve Stimulation Effective Date: March 3, 2003 Issued Date: November 1, 2003 Date Last Reviewed: 12/2002 General Policy
More information(12) United States Patent
USOO8688233B2 (12) United States Patent Bradley et al. (10) Patent No.: (45) Date of Patent: US 8,688,233 B2 Apr. 1, 2014 (54) (75) (73) (*) (21) (22) (65) (60) (51) (52) (58) SYSTEMAND METHOD FOR SPINAL
More informationSpinal Cord Stimulation for Multiple Sclerosis and Spinal Cord Injury
Spinal Cord Stimulation for Multiple Sclerosis and Spinal Cord Injury R. Davis Neural Engineering Clinic, PO Box 480, Rockport, Maine, 04856, U.S.A. Introduction Since 1973, spinal cord stimulation (SCS)
More informationClinical Data Summary: Avoid FFS Study
Atrial Pacing Lead with 1.1 mm Tip-to-Ring Spacing Clinical Data Summary: Avoid FFS Study A Multi-center, Randomized, Prospective Clinical Study Designed to Evaluate the 1699T Lead Clinical Data Summary:
More informationH F 1 0 T H E R A P Y R E I M B U R S E M E N T R E F E R E N C E G U I D E
HF10 therapy, delivered by the Nevro Senza System, is the high-frequency spinal cord stimulation technology designed to aid in the management of chronic intractable pain of the trunk/limbs without paresthesia.
More informationMODEL-BASED STIMULATION OPTIMIZATION FOR CHRONIC PAIN SUPPRESSION USING PERCUTANEOUS AND SURGICAL LEADS IN SPINAL CORD STIMULATION (SCS)
MODEL-BASED STIMULATION OPTIMIZATION FOR CHRONIC PAIN SUPPRESSION USING PERCUTANEOUS AND SURGICAL LEADS IN SPINAL CORD STIMULATION (SCS) Vishwanath Sankarasubramanian Members of the Graduation committee:
More informationProven pain therapy. Stimulating results.
Proven pain therapy. Stimulating results. Living with chronic pain can be difficult. We re here to help. We understand the physical and mental suffering associated with chronic pain. Not being able to
More informationAbout 70% of brachial plexus injuries are of. Neuromodulation in the Management of Pain from Brachial Plexus Injury. Case Report
Pain Physician 2008; 11:81-85 ISSN 1533-3159 Case Report Neuromodulation in the Management of Pain from Brachial Plexus Injury Silviu Brill, MD, and Itay Goor Aryeh, MD From: Pain Clinic, Department of
More informationMedical Policy An Independent Licensee of the Blue Cross and Blue Shield Association
Implanted Peripheral Nerve Stimulator (PNS) Page 1 of 6 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Implanted Peripheral Nerve Stimulator (PNS) for Pain
More informationPeripheral Subcutaneous Field Stimulation
Peripheral Subcutaneous Field Stimulation Policy Number: 7.01.139 Last Review: 9/2014 Origination: 7/2013 Next Review: 1/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide
More informationMedical Policy. Description/Scope. Position Statement. Rationale
Subject: Document#: Current Effective Date: 06/28/2017 Status: Reviewed Last Review Date: 05/04/2017 Description/Scope This document addresses occipital nerve stimulation (ONS), which involves delivering
More informationWireless Neuromodulation By A Minimally Invasive Technique For Chronic Refractory Pain. Report Of P reliminary Observations.
Wireless Neuromodulation By A Minimally Invasive Technique For Chronic Refractory Pain. Report Of P reliminary Observations. Authors: Bart Billet 1, MD Roel Wynendaele 1, MS Niek E. Vanquathem 2, BA Affilliations:
More informationInstead of feeling pain, the patient will experience tingling.
Spinal Cord Stimulation or SCS is a technique involving electrical stimulation of a precise part of the spinal cord. A very low energy current is used. This essentially shuts down the pain signals from
More informationTechnologies and architectures" Stimulator, electrodes, system flexibility, reliability, security, etc."
March 2011 Introduction" Basic principle (Depolarization, hyper polarization, etc.." Stimulation types (Magnetic and electrical)" Main stimulation parameters (Current, voltage, etc )" Characteristics (Muscular
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Implanted Peripheral Nerve Stimulator (PNS) for Pain Control Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Implanted Peripheral Nerve Stimulator (PNS)
More informationANATOMY AND PHYSIOLOGY OF NEURONS. AP Biology Chapter 48
ANATOMY AND PHYSIOLOGY OF NEURONS AP Biology Chapter 48 Objectives Describe the different types of neurons Describe the structure and function of dendrites, axons, a synapse, types of ion channels, and
More informationHF10 THERAPY 2018 Ambulatory Surgery Center Reimbursement and Coding Reference Guide
HF10 therapy, delivered by the Nevro Senza System, is the high-frequency spinal cord stimulation technology operated at 10,000 Hz designed to aid in the management of chronic intractable pain of the trunk
More informationDEFIBRILLATORS ATRIAL AND VENTRICULAR FIBRILLATION
1 DEFIBRILLATORS The two atria contract together and pump blood through the valves into the two ventricles, when the action potentials spread rapidly across the atria surface. After a critical time delay,
More informationSensory information processing, somato-sensory systems
mm? Sensory information processing, somato-sensory systems Recommended literature 1. Kandel ER, Schwartz JH, Jessel TM (2000) Principles of Neural Science, McGraw-Hill, Ch. xx. 2. Berne EM, Levy MN, Koeppen
More informationSacral Neuromodulation for Dysfunctional Voiders Workshop 1 Monday, August 23, 09:00 10:30
Sacral Neuromodulation for Dysfunctional Voiders Workshop 1 Monday, August 23, 09:00 10:30 Time Time Topic Speaker 09:00 09:05 Introduction to the aims of the workshop and the Magdy Hassouna participants
More informationArtificial neural networks: application to electrical stimulation of the human nervous system
Artificial neural networks: application to electrical stimulation of the human nervous system Richard B. North, M.D., J. Paul McNamee, M.S., Lee Wu, M.S., and Steven Piantadosi, M.D., Ph.D. Departments
More informationNANS Conference 2017 Highlights Matthew R. Kohler, MD January 2017
NAN Conference 2017 Highlights Matthew R. Kohler, MD January 2017 timulation timulation A dorsal root ganglion (or spinal ganglion) (also known as a posterior root ganglion), is a cluster of nerve cell
More informationCOMPUTER-OPTIMIZED NEUROSTIMULATION
KIM R. FOWLER and RICHARD B. NORTH COMPUTER-OPTIMIZED NEUROSTIMULATION An implantable device called a neurostimulator alleviates chronic pain by delivering electrical pulses to the nervous system of a
More informationSurgical Lead Implantation Guide
Surgical Lead Implantation Guide Neurostimulation Therapy for Chronic Pain Innovating for life. Medtronic, PrimeAdvanced, Restore, RestoreAdvanced, RestoreUltra, and Specify are registered trademarks of
More informationEE 791 Lecture 2 Jan 19, 2015
EE 791 Lecture 2 Jan 19, 2015 Action Potential Conduction And Neural Organization EE 791-Lecture 2 1 Core-conductor model: In the core-conductor model we approximate an axon or a segment of a dendrite
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: spinal_cord_stimulation 3/1980 10/2017 10/2018 10/2017 Description of Procedure or Service Spinal cord stimulation
More informationTechnical Note NEEDLE TIP DEPTH ASSESSMENT ON FORAMINAL OBLIQUE FLUOROSCOPIC VIEWS DURING CERVICAL RADIOFREQUENCY NEUROTOMY.
Technical Note Interventional Pain Management Reports ISSN 2575-9841 Volume 2, Number 4, pp127-131 2018, American Society of Interventional Pain Physicians NEEDLE TIP DEPTH ASSESSMENT ON FORAMINAL OBLIQUE
More informationSensory Analgesia. Pain Definitions a distressing feeling due to disease, bodily injury or organic disorder. uneasiness of mind or grief.
Sensory Analgesia Anesthesia- Analgesia- Partial or complete loss of sensation with or without loss of consciousness Relieving pain, being in a state without pain Pain Definitions a distressing feeling
More informationCHAPTER 10 THE SOMATOSENSORY SYSTEM
CHAPTER 10 THE SOMATOSENSORY SYSTEM 10.1. SOMATOSENSORY MODALITIES "Somatosensory" is really a catch-all term to designate senses other than vision, hearing, balance, taste and smell. Receptors that could
More informationCellular Bioelectricity
ELEC ENG 3BB3: Cellular Bioelectricity Notes for Lecture #30 Thursday, March 30, 2006 Nerve excitation: To evaluate the pattern of nerve activation that is produced by a particular electrode configuration,
More informationOutline. Animals: Nervous system. Neuron and connection of neurons. Key Concepts:
Animals: Nervous system Neuron and connection of neurons Outline 1. Key concepts 2. An Overview and Evolution 3. Human Nervous System 4. The Neurons 5. The Electrical Signals 6. Communication between Neurons
More informationSomatosensation. Recording somatosensory responses. Receptive field response to pressure
Somatosensation Mechanoreceptors that respond to touch/pressure on the surface of the body. Sensory nerve responds propotional to pressure 4 types of mechanoreceptors: Meissner corpuscles & Merkel discs
More informationHuman Anatomy. Spinal Cord and Spinal Nerves
Human Anatomy Spinal Cord and Spinal Nerves 1 The Spinal Cord Link between the brain and the body. Exhibits some functional independence from the brain. The spinal cord and spinal nerves serve two functions:
More informationOutline. Neuron Structure. Week 4 - Nervous System. The Nervous System: Neurons and Synapses
Outline Week 4 - The Nervous System: Neurons and Synapses Neurons Neuron structures Types of neurons Electrical activity of neurons Depolarization, repolarization, hyperpolarization Synapses Release of
More informationPocket Adaptor Kit FOR SPINAL CORD STIMULATION. Tip Cards
Pocket Adaptor Kit FOR SPINAL CORD STIMULATION Tip Cards model 74001 (1 4) model 74002 (2 4) The Pocket Adaptor Tip Cards are to be used for educational purposes only. Please refer to the Pocket Adaptor
More informationSurgical Leads. Directions for Use. CAUTION: Federal law restricts this device to sale, distribution and use by or on the order of a physician.
Surgical Leads Directions for Use CAUTION: Federal law restricts this device to sale, distribution and use by or on the order of a physician. 91078747-08 Content: 92190987 REV A Guarantees Boston Scientific
More informationSpinal cord stimulation for chronic pain management: mini-review
Review Article Med Biol Sci Eng 2018;1(1):1-5 https://doi.org/10.30579/mbse.2018.1.1.1 pissn 2586-5188 ㆍ eissn 2586-5196 Spinal cord stimulation for chronic pain management: mini-review Younghoon Jeon
More informationHuman Anatomy - Problem Drill 11: The Spinal Cord and Spinal Nerves
Human Anatomy - Problem Drill 11: The Spinal Cord and Spinal Nerves Question No. 1 of 10 Instructions: (1) Read the problem statement and answer choices carefully, (2) Work the problems on paper as needed,
More informationGLOSSARY OF TERMS ASSOCIATED WITH TENS
GLOSSARY OF TERMS ASSOCIATED WITH TENS ATP Adenosine Triphosphate that helps to promote protein synthesis. Accommodation Becoming accustomed to stimulation resulting in nerve and muscle fatigue. Acute
More informationChapter 17 Nervous System
Chapter 17 Nervous System 1 The Nervous System Two Anatomical Divisions Central Nervous System (CNS) Brain and Spinal Cord Peripheral Nervous System (PNS) Two Types of Cells Neurons Transmit nerve impulses
More informationDEFIBRILLATORS. Prof. Yasser Mostafa Kadah
DEFIBRILLATORS Prof. Yasser Mostafa Kadah Basics Defibrillation is definitive treatment for life-threatening cardiac arrhythmias such as ventricular fibrillation Defibrillation consists of delivering therapeutic
More informationBiomedical Instrumentation
University of Zagreb Faculty of Electrical Engineering and Computing Biomedical Instrumentation Electrical stimulation prof.dr.sc. Ratko Magjarević December 2015 Electrical stimulation The effect of electric
More informationCase Information: DORSAL ROOT GANGLION SPINAL CORD STIMULATION & POST HERPETIC NEURALGIA (PHN)
Author Information Full Names: Dipan Patel, MD Corey Hunter, MD Affiliation: Dipan Patel, MD: Garden State Pain Control, Clifton, New Jersey, USA Corey Hunter, MD Attending Pain Physician, Ainsworth Institute
More informationChapter 11 Introduction to the Nervous System and Nervous Tissue Chapter Outline
Chapter 11 Introduction to the Nervous System and Nervous Tissue Chapter Outline Module 11.1 Overview of the Nervous System (Figures 11.1-11.3) A. The nervous system controls our perception and experience
More informationPathways of proprioception
The Autonomic Nervous Assess Prof. Fawzia Al-Rouq Department of Physiology College of Medicine King Saud University Pathways of proprioception System posterior column& Spinocerebellar Pathways https://www.youtube.com/watch?v=pmeropok6v8
More informationMultiStim SWITCH and MultiStim SENSOR Setting the trend in nerve stimulation
MultiStim SWITCH and MultiStim SENSOR Setting the trend in nerve stimulation Plexus and Epidural Anaesthesia The essential advantage regarding safety MultiStim SENSOR and MultiStim SWITCH With MultiStim
More informationSummary of Selected Spinal Cord Stimulation Studies
Randomized Controlled Trials Kemler, et al. Effect of for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Neurosurg 2008. Kemler,
More informationIntroduction to Neurobiology
Biology 240 General Zoology Introduction to Neurobiology Nervous System functions: communication of information via nerve signals integration and processing of information control of physiological and
More informationLecture 14: The Spinal Cord
Lecture 14: The Spinal Cord M/O Chapters 16 69. Describe the relationship(s) between the following structures: root, nerve, ramus, plexus, tract, nucleus, and ganglion. 70. Trace the path of information
More informationAlgovita. MRI Procedure Guidelines. Spinal Cord Stimulation System. 201x
Algovita Spinal Cord Stimulation System MRI Procedure Guidelines Read this manual before performing an MRI scan on a patient implanted with an Algovita Spinal Cord Stimulation System. ONLY 201x Algovita
More informationPOLICIES AND PROCEDURE MANUAL
POLICIES AND PROCEDURE MANUAL Policy: MP021 Section: Medical Benefit Policy Subject: Dorsal Column Stimulation I. Policy: Dorsal Column StimulationRx therapy II. Purpose/Objective: To provide a policy
More informationSacral, ilioinguinal, and vasal nerve stimulation for treatment of pelvic, sacral, inguinal and testicular Pain.
Chapter 14 Sacral, ilioinguinal, and vasal nerve stimulation for treatment of pelvic, sacral, inguinal and testicular Pain. Introduction Sacral nerve root stimulation has been recognized as a treatment
More informationPERIOPERATIVE MANAGEMENT: CARDIAC PACEMAKERS AND DEFIBRILLATORS
PERIOPERATIVE MANAGEMENT: CARDIAC PACEMAKERS AND DEFIBRILLATORS DR SUSAN CORCORAN CARDIOLOGIST ONCE UPON A TIME.. Single chamber pacemakers Programmed at 70/min VVI 70 UNIPOLAR SYSTEMS A Unipolar Pacing
More informationCortical Control of Movement
Strick Lecture 2 March 24, 2006 Page 1 Cortical Control of Movement Four parts of this lecture: I) Anatomical Framework, II) Physiological Framework, III) Primary Motor Cortex Function and IV) Premotor
More informationLong Term Monitoring of the Intrinsic Ventricular Monophasic Action Potential with an Implantable DDD Pacemaker
May 1998 79 Long Term Monitoring of the Intrinsic Ventricular Monophasic Action Potential with an Implantable DDD Pacemaker T. LAWO, J. BARMEYER Abteilung für Kardiologie, Universitätsklinik Bergmannsheil,
More informationManual Defibrillators, Automatic External Defibrillators, Cardioversion, and External Pacing. D. J. McMahon cewood rev
Manual Defibrillators, Automatic External Defibrillators, Cardioversion, and External Pacing D. J. McMahon 141001 cewood rev 2017-10-04 Key Points Defibrillators: - know the definition & electrical value
More informationManual Defibrillators, Automatic External Defibrillators, Cardioversion, and External Pacing
Manual Defibrillators, Automatic External Defibrillators, Cardioversion, and External Pacing Key Points Defibrillators: - know the definition & electrical value of a joule - monophasic vs biphasic types:
More informationElectrostimulation Part 3: Bladder dysfunctions
GBM8320 Dispositifs Médicaux Intelligents Electrostimulation Part 3: Bladder dysfunctions Mohamad Sawan et al Laboratoire de neurotechnologies Polystim!!! http://www.cours.polymtl.ca/gbm8320/! mohamad.sawan@polymtl.ca!
More informationPrinciples of Electrical Currents. HuP 272
Principles of Electrical Currents HuP 272 Electricity is an element of PT modalities most frightening and least understood. Understanding the basis principles will later aid you in establishing treatment
More informationGross Morphology of Spinal Cord
Gross Morphology of Spinal Cord Lecture Objectives Describe the gross anatomical features of the spinal cord. Describe the level of the different spinal segments compared to the level of their respective
More informationImageReady MRI Head Only Guidelines for Spectra WaveWriter Spinal Cord Stimulator System
ImageReady MRI Head Only Guidelines for Spectra WaveWriter Spinal Cord Stimulator System CAUTION: Federal law restricts this device to sale, distribution and use by or on the order of a physician. 91171762-01
More informationThe Role of the Neuromodulation in Management of Chronic Pain
The Role of the Neuromodulation in Management of Chronic Pain Adnan Al-Kaisy, MB ChB, FRCA, FFPMRCA, FIPP Clinical Lead of the Pain Management & Neuromodulation Centre Guy s & St Thomas Hospital, London,
More informationGBM8320 Dispositifs Médicaux Intelligents. Electrostimulation. Part 3: Bladder dysfunctions
GBM8320 Dispositifs Médicaux Intelligents Electrostimulation Part 3: Bladder dysfunctions Mohamad Sawan et al Laboratoire de neurotechnologies Polystim!!! http://www.cours.polymtl.ca/gbm8320/! mohamad.sawan@polymtl.ca!
More informationClinical Policy Title: Spinal cord stimulators for chronic pain
Clinical Policy Title: Spinal cord stimulators for chronic pain Clinical Policy Number: 03.03.01 Effective Date: October 1, 2014 Initial Review Date: March 19, 2014 Most Recent Review Date: April 19, 2017
More informationHUMAN MOTOR CONTROL. Emmanuel Guigon
HUMAN MOTOR CONTROL Emmanuel Guigon Institut des Systèmes Intelligents et de Robotique Université Pierre et Marie Curie CNRS / UMR 7222 Paris, France emmanuel.guigon@upmc.fr e.guigon.free.fr/teaching.html
More informationCase Report. Ilioinguinal Peripheral Nerve Stimulation. Juan A. Ramos, MD 1, Andrew J. McNeil, DO 2, Ted F. Gingrich, MD 3
Case Report Interventional Pain Management Reports Volume 1, Number 2, pp93-97 2017, American Society of Interventional Pain Physicians Combined Ultrasound and Fluoroscopic Guidance for Percutaneous Ilioinguinal
More informationSpinal Cord Stimulation Hani N. Sabbah, Ph.D., FACC, FCCP, FAHA Professor of Medicine Wayne State University & Director of Cardiovascular Research
Spinal Cord Stimulation Hani N. Sabbah, Ph.D., FACC, FCCP, FAHA Professor of Medicine Wayne State University & Director of Cardiovascular Research Henry Ford Health System Disclosure Information ESC 2011
More information10.1: Introduction. Cell types in neural tissue: Neurons Neuroglial cells (also known as neuroglia, glia, and glial cells) Dendrites.
10.1: Introduction Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Cell types in neural tissue: Neurons Neuroglial cells (also known as neuroglia, glia, and glial
More informationSinus rhythm with premature atrial beats 2 and 6 (see Lead II).
Cardiac Pacemaker Premature Beats When one of ectopic foci becomes irritable, it may spontaneously fire, leading to one or more premature beats. Atrial and junctional foci may become irritable from excess
More informationSpinal cord stimulation (SCS) is a safe and effective procedure
ORIGINAL ARTICLE A 2-center Comparative Study on Tonic Versus Burst Spinal Cord Stimulation Amount of Responders and Amount of Pain Suppression Dirk De Ridder, MD, PhD,*w Mathieu W.P.M. Lenders, MD,zy
More informationOmar Sami. Muhammad Abid. Muhammad khatatbeh
10 Omar Sami Muhammad Abid Muhammad khatatbeh Let s shock the world In this lecture we are going to cover topics said in previous lectures and then start with the nerve cells (neurons) and the synapses
More informationChapter 7. The Nervous System: Structure and Control of Movement
Chapter 7 The Nervous System: Structure and Control of Movement Objectives Discuss the general organization of the nervous system Describe the structure & function of a nerve Draw and label the pathways
More informationPeripheral Subcutaneous Field Stimulation. Description
Subject: Peripheral Subcutaneous Field Stimulation Page: 1 of 6 Last Review Status/Date: June 2016 Peripheral Subcutaneous Field Stimulation Description Peripheral subcutaneous field stimulation (PSFS,
More informationElectrophysiology. General Neurophysiology. Action Potentials
5 Electrophysiology Cochlear implants should aim to reproduce the coding of sound in the auditory system as closely as possible, for best sound perception. The cochlear implant is in part the result of
More informationTranscutaneous Electrical Nerve Stimulation (TENS)
Transcutaneous Electrical Nerve Stimulation (TENS) Authors: SCIRE Community Team Reviewed by: Amrit Dhaliwal, PT Last updated: July 27, 2017 Transcutaneous electrical nerve stimulation (TENS) is a non-drug
More informationRead this manual before performing an MRI scan on a patient implanted with an Algovita Spinal Cord Stimulation System.
Algovita Spinal Cord Stimulation System MRI Procedure Guidelines Read this manual before performing an MRI scan on a patient implanted with an Algovita Spinal Cord Stimulation System. ONLY 0300-000175-001
More information